Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 2.000% 3/1
-
Number of holders
-
42
-
Total 13F principal, excl. options
-
287,504,200
-
Principal change
-
-1,508,500
-
Total reported value, excl. options
-
$250,404,674
-
Value change
-
-$1,633,019
-
Number of buys
-
17
-
Number of sells
-
14
-
Price
-
$0.8666
Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 as of Q2 2025
As of 30 Jun 2025 AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 had 48 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $287,504,200 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Linden Advisors LP, Wellesley Asset Management, CAMDEN ASSET MANAGEMENT L P /CA, MACKAY SHIELDS LLC, WOLVERINE ASSET MANAGEMENT LLC, Empyrean Capital Partners, LP, Calamos Advisors LLC, MORGAN STANLEY, Jump Financial, LLC, and LAZARD ASSET MANAGEMENT LLC.
This table shows 48 bond principal holders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.